NCT07477236 MyVitalC: Sleep and Everyday Headache Management
| NCT ID | NCT07477236 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Efforia, Inc |
| Condition | Sleep |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-01-24 |
| Primary Completion | 2027-01-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-01-24 with a primary completion date of 2027-01-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sleep disturbance and recurring headaches can negatively affect daily functioning, mood, and productivity. MyVitalC (ESS60 in extra virgin olive oil) is a commercially available dietary supplement that has generated anecdotal claims related to sleep quality and headache relief; however, human data remain limited. This real-world observational study is designed to help participants evaluate whether use of MyVitalC is associated with changes in sleep disturbance and headache frequency or severity in their own daily lives. Participants will complete a four-week baseline observation period without the intervention, followed by six weeks of daily MyVitalC use, with weekly self-reported assessments. Participants serve as their own control, allowing for within-person comparison of outcomes before and during product use.
Eligibility Criteria
Inclusion Criteria: * Adults of legal age of consent * Able to provide informed consent * Willing to complete weekly assessments and daily logs * Able to purchase and use the study product Exclusion Criteria: * Have known allergies to olive oil or product components * Are pregnant or breastfeeding * Have severe or chronic headache disorders * Have significant gastrointestinal conditions * Have medical conditions that could be exacerbated by supplement use * Have concerns about dizziness, fatigue, or mood disturbances * Are subject to organizational or legal restrictions on supplement use
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07477236 clinical trial?
This trial is open to participants of all sexes, studying Sleep. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07477236 currently recruiting?
Yes, NCT07477236 is actively recruiting participants. Contact the research team at help@efforia.com for enrollment information.
Where is the NCT07477236 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07477236 clinical trial?
NCT07477236 is sponsored by Efforia, Inc. The trial plans to enroll 100 participants.